Skip to content

Immucell Corp

ICCC· NasdaqCore metricsCIK 811641

In vitro & in vivo diagnostic substances19 peers

Last sale
Nov 6, 2026 · -0.80%
Market cap
$89.64M
9.09M shares
Filings
799
$8.04M
Q3 2026+4.3% FY25 yoy
$952.51K
Q3 2026N/M FY25 yoy
$957.77K
Q3 2026N/M FY25 yoy
$5.09M
Q3 2026derivedN/M FY25 yoy
$0.10
Q3 2026N/M FY25 yoy
$7.91M
Q3 2026+1.3% FY25 yoy
$89.64M
47.7×
2.7×
2.7×
6.03%
—

Twelve months to Sep 30, 2026 · derived

Price

$9.86+57.51%+$3.60past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$27.64MFY 2025
$27.64M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$27,644,174reported
FY 20242024-12-31$26,493,169reported
FY 20232023-12-31$17,471,669reported
FY 20222022-12-31$18,567,962reported
FY 20212021-12-31$19,242,969reported
FY 20202020-12-31$15,342,204reported
FY 20192019-12-31$13,722,872reported
FY 20182018-12-31$10,986,297reported
FY 20172017-12-31$10,431,091reported
FY 20162016-12-31$9,543,961reported
FY 20152015-12-31$10,228,689reported
FY 20142014-12-31$7,596,874reported

Segments

Revenue by Segments, FY2021 to FY2025FY2021Mastitis · FY2021 · $143.28KOther · FY2021 · $166.60KScours · FY2021 · $18.93MFY2022Mastitis · FY2022 · $154.56KOther · FY2022 · $1.46KScours · FY2022 · $18.41MFY2023Mastitis · FY2023 · $177.74KScours · FY2023 · $17.29MFY2024Corporate Segment, Scours · FY2024 · $26.31MCorporate Segment, Mastitis · FY2024 · $178.92KFY2025Corporate Segment, Scours · FY2025 · $27.45MCorporate Segment, Mastitis · FY2025 · $196.39K
LineFY2025ShareChange
Corporate Segment, Scours$27.45M99%+4.3%
Corporate Segment, Mastitis$196.39K0.7%+9.8%
Mastitis———
Other———
Scours———
Total$27.64M

From the 10-K filed Mar 30, 2026ICCC

In vitro & in vivo diagnostic substances

Immucell Corp is the 8th largest of the 20 covered companies the SEC files under this code, by revenue. SIC 2835

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Immucell Corp · CIK 811641 · Engraved from SEC EDGAR